Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
---|---|---|---|---|---|
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 3852 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 4757 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 11364 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 13314 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 15831 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 17152 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 19070 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 52922 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 171158 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | Peak area | SCA | N/A |